scispace - formally typeset
P

Paul M. Grandgenett

Researcher at Eppley Institute for Research in Cancer and Allied Diseases

Publications -  44
Citations -  8513

Paul M. Grandgenett is an academic researcher from Eppley Institute for Research in Cancer and Allied Diseases. The author has contributed to research in topics: Pancreatic cancer & Cancer. The author has an hindex of 18, co-authored 34 publications receiving 5897 citations. Previous affiliations of Paul M. Grandgenett include University of Nebraska Medical Center.

Papers
More filters
Journal ArticleDOI

Tumour exosome integrins determine organotropic metastasis

TL;DR: It is demonstrated that exosomes from mouse and human lung-, liver- and brain-tropic tumour cells fuse preferentially with resident cells at their predicted destination, namely lung fibroblasts and epithelial cells, liver Kupffer cells and brain endothelial cells.
Journal ArticleDOI

Organoid profiling identifies common responders to chemotherapy in pancreatic cancer

Hervé Tiriac, +73 more
- 31 May 2018 - 
TL;DR: A pancreatic cancer patient-derived organoid (PDO) library is generated that recapitulates the mutational spectrum and transcriptional subtypes of primary Pancreatic cancer and proposes that combined molecular and therapeutic profiling of PDOs may predict clinical response and enable prospective therapeutic selection.
Journal ArticleDOI

Extracellular Vesicle and Particle Biomarkers Define Multiple Human Cancers

Ayuko Hoshino, +136 more
- 20 Aug 2020 - 
TL;DR: EVP proteins can serve as reliable biomarkers for cancer detection and determining cancer type, and a panel of tumor-type-specific EVP proteins in TEs and plasma are defined, which can classify tumors of unknown primary origin.